Literature DB >> 3440865

A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis.

S C Watkins1, M J Cullen.   

Abstract

Quantitative and qualitative ultrastructural analyses were made of selected small muscle fibres from muscle biopsies from 23 patients with Duchenne muscular dystrophy (DMD) and 10 with polymyositis. It is argued that the fibres selected were regenerating. The myofibrillar content of the fibres was similar in both samples. In both there was considerable misalignment of the myofibrils but their orientation tended to improve as the content increased. The mitochondrial content was similar in the two samples but there were more ultrastructural abnormalities in the DMD population. The concentration of glycogen was elevated and the sarcoplasmic reticulum (SR) was much more commonly dilated in the DMD patients. Dilated SR is the prenecrotic change seen most frequently in mature muscle fibres in DMD and seems to be the first ultrastructural manifestation of the disease process. Its occurrence in the regenerating fibres suggest that the primary genetic lesion is being recapitulated in successive generations of fibres.

Entities:  

Mesh:

Year:  1987        PMID: 3440865     DOI: 10.1016/0022-510x(87)90017-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress.

Authors:  Wen-hai Fan; Yi Hou; Fan-kai Meng; Xiao-fei Wang; Yi-nan Luo; Peng-fei Ge
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

2.  Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells.

Authors:  Peng-Fei Ge; Ji-Zhou Zhang; Xiao-Fei Wang; Fan-Kai Meng; Wen-Chen Li; Yong-Xin Luan; Feng Ling; Yi-Nan Luo
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

3.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

4.  Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy.

Authors:  M J Cullen; E Jaros
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

6.  Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy.

Authors:  Y Campos; J Arenas; A Cabello; J J Gomez-Reino
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

7.  The chicken dystrophin cDNA: striking conservation of the C-terminal coding and 3' untranslated regions between man and chicken.

Authors:  C Lemaire; R Heilig; J L Mandel
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

8.  Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.

Authors:  Florence Robriquet; Aurélie Lardenois; Candice Babarit; Thibaut Larcher; Laurence Dubreil; Isabelle Leroux; Céline Zuber; Mireille Ledevin; Jack-Yves Deschamps; Yves Fromes; Yan Cherel; Laetitia Guevel; Karl Rouger
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

9.  Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice.

Authors:  David I Stapleton; Xianzhong Lau; Marcelo Flores; Jennifer Trieu; Stefan M Gehrig; Annabel Chee; Timur Naim; Gordon S Lynch; René Koopman
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Sulforaphane inhibits growth of phenotypically different breast cancer cells.

Authors:  Anna Pawlik; Aleksandra Wiczk; Angelika Kaczyńska; Jędrzej Antosiewicz; Anna Herman-Antosiewicz
Journal:  Eur J Nutr       Date:  2013-02-07       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.